About pRxcision

The startup has developed an artificial intelligence platform that continuously monitors electronic medical records to integrate real-time clinical and microbiological data for personalized treatment of critical infections. This technology enhances antibiotic decision support, enabling healthcare providers to optimize antimicrobial use and improve patient outcomes globally.

```xml <problem> Clinicians often struggle to synthesize vast amounts of real-time clinical and microbiological data from electronic medical records (EMRs) to make informed decisions about antibiotic prescriptions for critical infections. This can lead to suboptimal antimicrobial use, contributing to antibiotic resistance and potentially worsening patient outcomes. </problem> <solution> The startup offers an AI-powered platform that continuously analyzes EMR data, integrating clinical information with microbiological results to provide personalized treatment recommendations for patients with critical infections. By leveraging real-time data analysis, the platform enhances antibiotic decision support, enabling healthcare providers to optimize antimicrobial selection and dosing. This leads to more effective treatment strategies, reduced antibiotic resistance, and improved patient outcomes. The platform aims to streamline the decision-making process, ensuring that patients receive the most appropriate and timely antibiotic therapy. </solution> <features> - Continuous monitoring of electronic medical records for real-time data integration - AI-driven analysis of clinical and microbiological data - Personalized antibiotic treatment recommendations based on patient-specific information - Decision support tools to optimize antimicrobial selection and dosing - Integration with existing hospital information systems and EMRs - Real-time alerts for potential antibiotic resistance patterns - Customizable dashboards for tracking antibiotic usage and patient outcomes </features> <target_audience> The primary target audience includes hospitals, healthcare systems, infectious disease specialists, and antimicrobial stewardship programs seeking to improve antibiotic prescribing practices and patient outcomes. </target_audience> ```

What does pRxcision do?

Where is pRxcision located?

pRxcision is based in Schenectady, United States.

How much funding has pRxcision raised?

pRxcision has raised 3130000.

Location

Schenectady, United States

Funding

3130000

Employees

2 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

pRxcision

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

prxcision.com 50+

Schenectady, United States

Funding

Estimated Funding

$3M+

Team (<5)

No team information available.

Company Description

Problem

Clinicians often struggle to synthesize vast amounts of real-time clinical and microbiological data from electronic medical records (EMRs) to make informed decisions about antibiotic prescriptions for critical infections. This can lead to suboptimal antimicrobial use, contributing to antibiotic resistance and potentially worsening patient outcomes.

Solution

The startup offers an AI-powered platform that continuously analyzes EMR data, integrating clinical information with microbiological results to provide personalized treatment recommendations for patients with critical infections. By leveraging real-time data analysis, the platform enhances antibiotic decision support, enabling healthcare providers to optimize antimicrobial selection and dosing. This leads to more effective treatment strategies, reduced antibiotic resistance, and improved patient outcomes. The platform aims to streamline the decision-making process, ensuring that patients receive the most appropriate and timely antibiotic therapy.

Features

Continuous monitoring of electronic medical records for real-time data integration

AI-driven analysis of clinical and microbiological data

Personalized antibiotic treatment recommendations based on patient-specific information

Decision support tools to optimize antimicrobial selection and dosing

Integration with existing hospital information systems and EMRs

Real-time alerts for potential antibiotic resistance patterns

Customizable dashboards for tracking antibiotic usage and patient outcomes

Target Audience

The primary target audience includes hospitals, healthcare systems, infectious disease specialists, and antimicrobial stewardship programs seeking to improve antibiotic prescribing practices and patient outcomes.